News

SAN DIEGO, May 26, 2026 (GLOBE NEWSWIRE) — Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or “the Company”), a biotechnology company pioneering the development of targeted genetic medicines, announced that two abstracts showcasing the Company’s […]

SAN DIEGO–(BUSINESS WIRE)–Autobahn Therapeutics, Inc., a biotechnology company developing restorative treatments for people affected by neuropsychiatric disorders, today announced that the U.S. Food and Drug Administration (FDA) granted Fast Track designation to elunetirom, the Company’s […]

SAN DIEGO, May 22, 2026 (GLOBE NEWSWIRE) — Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or “the Company”), a biotechnology company pioneering the development of targeted genetic medicines, today advised that its Financial Statements included […]

SAN DIEGO–(BUSINESS WIRE)–UC San Diego’s Living Lab at Belmont Village Recognized for Advancing Innovation in Senior Living Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks

As an outbreak of Ebola in central Africa continues to worsen, the federal government has tapped a little-known biotech in San Diego to provide doses of an experimental antibody that may be used to treat […]

The money continues to flow for drug development startups that are working on inflammatory and immunology medicines licensed from other companies. A new San Diego biotech called cAMPfield Therapeutics is the latest to secure backing […]

SCHLIEREN, Switzerland & SAN DIEGO–(BUSINESS WIRE)– #Imaging–InSphero AG, a global leader in advanced 3D in vitro models and services for drug safety and efficacy testing, today announced the acquisition of PhenoVista Biosciences, Inc., a premier […]

SAN DIEGO–(BUSINESS WIRE)–Autobahn Therapeutics, Inc., a biotechnology company developing restorative treatments for people affected by neuropsychiatric disorders, today announced the presentation of new preclinical data for elunetirom (ABX-002), the company’s lead asset currently in Phase […]

LAUSANNE, Switzerland & SAN DIEGO–(BUSINESS WIRE)– #Cardiology–HAYA Therapeutics Announces First Cohort Dosed in Phase 1 Trial of HTX-001, an Investigational Cellular Reprogramming Therapy for Cardiac Fibrosis Click here to view original post Click Here to […]

SAN DIEGO–(BUSINESS WIRE)– #biosciences–Mispro announced today that it will open a new 7,000-square-foot contract vivarium facility at Genesis Science Center in San Diego’s Sorrento Mesa submarket, further expanding the company’s national footprint across major U.S. […]

SAN DIEGO, May 20, 2026 (GLOBE NEWSWIRE) — Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio®” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant […]

A new study in Science Signaling identifies a previously overlooked control point in receptor tyrosine kinase (RTK) signaling, one that operates not at the plasma membrane, but at the Golgi. The research, published as “Oncogenic […]